Device
sham transcranial Photobiomodulation
sham transcranial Photobiomodulation is a medical device with 4 clinical trials. Currently 3 active trials ongoing.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Active Trials
3(75%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
0.0%
0 of 0 finished
Non-Completion Rate
0.0%
0 ended early
Currently Active
3
trials recruiting
Total Trials
4
all time
Status Distribution
Active(4)
Detailed Status
Recruiting2
Not yet recruiting1
Active, not recruiting1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
3
Success Rate
N/A
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
not_yet_recruiting125%
recruiting250%
active_not_recruiting125%
Recent Activity
3 active trials
Showing 4 of 4
recruitingnot_applicable
Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment
NCT07287527
not_yet_recruitingnot_applicable
Effects of Transcranial Photobiomodulation in ADHD
NCT07203092
recruitingnot_applicable
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
NCT05802680
active_not_recruitingnot_applicable
Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome
NCT04668001
Clinical Trials (4)
Showing 4 of 4 trials
NCT07287527Not Applicable
Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment
NCT07203092Not Applicable
Effects of Transcranial Photobiomodulation in ADHD
NCT05802680Not Applicable
Neurocognitive Effects of Non-Invasive Near-Infrared Light Stimulation
NCT04668001Not Applicable
Transcranial Photobiomodulation With Near-Infrared Light for Language in Individuals With Down Syndrome
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4